NRC Health
NRC
$18.62
-$0.31-1.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 34.80M | 35.19M | 34.61M | 34.04M | 33.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.80M | 35.19M | 34.61M | 34.04M | 33.55M |
| Cost of Revenue | 13.65M | 13.94M | 12.40M | 12.97M | 13.06M |
| Gross Profit | 21.16M | 21.26M | 22.20M | 21.06M | 20.49M |
| SG&A Expenses | 13.42M | 7.79M | 12.27M | 17.73M | 10.36M |
| Depreciation & Amortization | 2.17M | 2.15M | 2.20M | 1.74M | 1.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.23M | 23.87M | 26.87M | 32.45M | 24.96M |
| Operating Income | 5.57M | 11.32M | 7.74M | 1.59M | 8.60M |
| Income Before Tax | 4.38M | 3.27M | 6.27M | 581.00K | 7.72M |
| Income Tax Expenses | 1.16M | 1.47M | 2.15M | 687.00K | 1.94M |
| Earnings from Continuing Operations | 3.22M | 1.80M | 4.12M | -106.00K | 5.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.22M | 1.80M | 4.12M | -106.00K | 5.79M |
| EBIT | 5.57M | 11.32M | 7.74M | 1.59M | 8.60M |
| EBITDA | 7.74M | 13.47M | 9.93M | 3.33M | 10.14M |
| EPS Basic | 0.14 | 0.08 | 0.18 | -0.01 | 0.25 |
| Normalized Basic EPS | 0.13 | 0.28 | 0.18 | 0.02 | 0.21 |
| EPS Diluted | 0.14 | 0.07 | 0.18 | -0.01 | 0.25 |
| Normalized Diluted EPS | 0.12 | 0.28 | 0.18 | 0.02 | 0.21 |
| Average Basic Shares Outstanding | 21.80M | 21.79M | 22.13M | 22.66M | 22.97M |
| Average Diluted Shares Outstanding | 21.91M | 21.81M | 22.13M | 22.66M | 22.97M |
| Dividend Per Share | 0.16 | 0.16 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 112.51% | 150.06% | 67.35% | -2,579.25% | 47.87% |